Print

Can tumor tests identify more breast cancer patients who can safely skip chemotherapy?

https://www.facingourrisk.org/XRAY/skipping-chemotherapy

Two studies presented at the December 2020 San Antonio Breast Cancer Symposium looked at how tumor testing can identify patients who may benefit the most and the least from chemotherapy. (3/4/21)

Este artículo está disponible en español.

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following studies are enrolling people with early-stage ER-positive, HER2-negative breast cancer. 

Several other clinical trials for patients with early-stage breast cancer can be found here.

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.